| 5741 |
Why is System for TB Elimination in Private Sector (STEPS) Unique? |
20/04/2024 |
|
| 5743 |
Ensuring Complete Notification from a STEPS Centre |
20/04/2024 |
|
| 5746 |
Role of Hospital Management at a STEPS centre |
20/04/2024 |
|
| 5745 |
Role of STEPS Nodal officer |
20/04/2024 |
|
| 5748 |
Assurance of Quality services at STEPS centre |
20/04/2024 |
|
| 6123 |
NTEP support to Private Practitioners/Hospitals |
21/04/2024 |
|
| 5716 |
Private Practitioners |
21/04/2024 |
|
| 5283 |
Designing partnerships- An introduction |
21/04/2024 |
Partnerships and Multisectoral Engagement |
| 5039 |
3 I strategy for TB-HIV |
30/04/2024 |
TB Comorbidities and special conditions |
| 3196 |
ART Centre |
03/05/2024 |
TB Comorbidities and special conditions |
| 1803 |
DR-TB Treatment Care Cascade |
03/05/2024 |
DR-TB and PMDT |
| 262 |
Diabetes among people with TB |
03/05/2024 |
TB Comorbidities and special conditions |
| 4863 |
TB and Diabetes comorbidity |
03/05/2024 |
TB Comorbidities and special conditions |
| 6124 |
Health System |
07/05/2024 |
|
| 5875 |
Comparison between Health program and project |
07/05/2024 |
|
| 5873 |
A Health Program |
07/05/2024 |
|
| 6004 |
NTEP Training and Capacity Needs |
08/05/2024 |
|
| 6134 |
Multiple BCG vaccination Policy- Country wise profile |
13/05/2024 |
|
| 359 |
Development of Drug Resistance in MTB |
13/05/2024 |
DR-TB and PMDT |
| 6132 |
Indian studies on Adult BCG vaccination |
15/05/2024 |
|
| 6147 |
aBCG vaccine implementation study- Beneficiary Consent for Adult BCG Vaccination |
15/05/2024 |
|
| 6143 |
aBCG vaccine implementation study-Study Population : Exclusion Criteria |
15/05/2024 |
|
| 6146 |
aBCG vaccine implementation study- Ethical Consideration |
15/05/2024 |
|
| 6148 |
aBCG vaccine implementation study- Monitoring and Safety Evaluation Plan |
15/05/2024 |
|
| 6149 |
aBCG vaccine implementation study- Monitoring and Statistical Analysis Plan for Impact on TB Notification |
15/05/2024 |
|
| 6139 |
aBCG vaccine implementation study-Study methodology and objectives |
15/05/2024 |
|
| 6142 |
aBCG vaccine implementation study- Study Population: Inclusion Criteria |
15/05/2024 |
|
| 6141 |
aBCG vaccine implementation study- Study settings |
15/05/2024 |
|
| 6140 |
aBCG vaccine implementation study- Expected Study Outcomes |
15/05/2024 |
|
| 6145 |
aBCG vaccine implementation study- Preparatory Activities |
15/05/2024 |
|
